News I Sino Bioengineering

Antibody-drug conjugates (ADCs) represent one of the defining therapeutic modalities advancing precision oncology. As engineered biotherapeutics, ADCs leverage the antigen-recognitio……

CPHI Milan was a major talking point in the pharmaceutical industry over the past week. Numerous posts and news coverage about the exhibition circulated across social media and WeCha……

CPHI Milan 2026 concluded successfully on 8 October at Fiera Milano, Italy, after a three-day run. As a premier global pharmaceutical networking platform, the exhibition gathered pha……

Biopharma 4.0 is underpinned by four definitive attributes: digitalization, intelligent manufacturing, operational continuity, and modularity. End-to-end continuous manufacturing rep……

The landscape of oncological therapy is undergoing profound transformation, with precision-targeted and individualized treatment modalities emerging as the core trend of innovative ……

Driven by global population expansion, surging market demand for animal-derived food products, and the large-scale, intensive transformation of livestock breeding models, the strate……

Within the pharmaceutical industry, compliance and operational efficiency are often regarded as opposing imperatives. True intelligent manufacturing, however, redefines compliance no……

Lyophilization (freeze-drying) is an indispensable core process in the manufacturing of sterile pharmaceutical products, whose contamination control performance fundamentally determ……

Sterile liquid formulation constitutes a critical unit operation in biopharmaceutical manufacturing. Process performance including homogeneous liquid blending, robust sterility ass……

As the National Medical Products Administration (NMPA) accelerates its accession to the Pharmaceutical Inspection Co-operation Scheme (PIC/S), China’s pharmaceutical regulatory syst……

In the vast landscape of modern biopharmaceuticals, the purification process for monoclonal antibodies (mAbs) has already achieved relative maturity and standardization. However, whe……

In the vast landscape of modern biopharmaceuticals, from life-saving monoclonal antibodies and cutting-edge gene viral vectors to a broad spectrum of innovative medicines, an invisib……

In recent years, Cell and Gene Therapy (CGT), one of the most groundbreaking technological sectors in life sciences, is rapidly transforming the traditional paradigm of disease treat……

In recent years, CAR-T cell therapy has achieved groundbreaking advances in hematologic malignancies, offering new treatment options for many patients with refractory diseases. Never……

With the rapid advancement of artificial intelligence (AI), an increasing number of pharmaceutical manufacturers are exploring AI deployment across R&D, production and quality ma……

On 23 September 2026, PIC/S published the new version PE 009-18 of the PIC/S GMP Guide. This new PE 009-18 edition totals 400 pages, consisting of Part I (Basic GMP Requirements for ……